Overview: Transferrin TestIntroduction: The Transferrin Test measures transferrin to diagnose iron deficiency anemia, causing fatigue. Aligned with 2023 ASH guidelines, it uses biochemical methods for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected anemia.
Other Names: Transferrin Assay, Iron-Binding Protein Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Transferrin testing began in the 1950s with anemia research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures transferrin to diagnose iron deficiency anemia, guides treatment, and evaluates patients with fatigue.
Test Parameters: 1. Transferrin Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of fatigue or anemia symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, pallor, or history of anemia. Include current medications, especially iron supplements.
Consent: Written consent required, detailing the tests purpose, anemia implications, and risks of sample collection.
Procedural Considerations: Uses nephelometry or turbidimetry to measure transferrin levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for anemia diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Inflammation may alter transferrin levels.
Clinical Significance: Low transferrin confirms iron deficiency anemia, guiding iron supplementation. Elevated levels may suggest iron overload, requiring further testing.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Ferritin, TIBC, or CBC to confirm iron deficiency anemia diagnosis.
Test Limitations: Non-specific in inflammatory states; clinical correlation is needed. Sample quality affects sensitivity.
References: ASH Anemia Guidelines, 2023; Blood, Andrews NC, 2022.
